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Abstract
Background: Otitis media is a more frequent occurrence in children, and the disease may progress from an acute to
chronic state if appropriate and timely intervention is not initiated.
Methods: A total of 212 children aged 6 months to 10 years were examined and treated for otitis media, in a
13-month hospital-based study.
Results: Acute otitis media was diagnosed in 130 (61.3 per cent) of the patients. There were 82 (38.7 per cent)
chronic suppurative otitis media cases. The incidence of acute otitis media and chronic suppurative otitis media in
the first year of life was 54.6 per cent and 45.1 per cent respectively. Chronic suppurative otitis media patients were
assigned to one of three treatment groups. Recovery occurred in 70.4 per cent of amoxicillin-treated patients, in 88.9
per cent of amoxicillin-clavulanic acid treated patients and in 96.4 per cent of culture and antibiotic sensitivity test
patients. Relapses were seen only in the amoxicillin (five cases) and amoxicillin-clavulanic acid (two cases) groups.
Conclusion: The success rate in patients treated with antibiotics makes this option mandatory for an established
diagnosis.
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Introduction
Otitis media is a leading cause (probably alongside
diarrhoea1) of childhood morbidity. It can have a crip-
pling effect on a child’s development. Furthermore, it
is associated with significant economic and social
burdens on the child’s family and the healthcare
system. For instance, in the USA, between three and
five billion US dollars were reportedly spent on otitis
media in the 1990s.2,3
Otitis media also constitutes one of the clinical infec-
tions for which antibiotics are frequently prescribed in
developing countries.4 In a previous study conducted
in Nigeria, unorthodox aural toilet practices, which
include the use of plant fibres and other non-sterile
objects, were identified as significant contributors to
the development of otitis media.5
Age delineation has shown that the highest incidence
of acute otitis media occurs in children aged between
6 and 12 months, and infection is less likely to
resolve spontaneously (as it does with older children)
in this age group.6 This underlines the prescription of
antibiotics for this age group by many physicians.
Nevertheless, otitis media with effusion can affect
children of all ages.
Otitis media is asymptomatic and in a small percent-
age of children it is associated with hearing loss.3 In
contrast, chronic suppurative otitis media (CSOM)
occurs as a complication of otitis media with effusion.
The prevalence of CSOM in children with hearing loss
greater than 40 dB has been reported as being up to 20
per cent in developing countries.7
The categorisation of otitis media as acute, effusive,
chronic and suppurative is based on diagnostic features.
Chronic suppurative otitis media is usually painless,
with tympanic perforation and discharge. Affected
patients report bouts of recurring ear discharge, sore
throat, cold and cough.8–10 Acute otitis media patients,
however, present with pain, with or without otorrhoea.
The pain in acute otitis media is mastoidal. In contrast,
in acute otitis externa the pain is tragal, and the discharge
is foul-smelling, non-mucoid and less profuse.11 More
frequently, infection characterises CSOM; the microbes
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come from the upper respiratory tract or may be intro-
duced exogenously.5,12
There is controversy regarding whether to prescribe
antibiotics for otitis media. It is suggested that antibio-
tics can prevent progression of acute otitis media to the
chronic stage.13–16 However, the unregulated use of
antibiotics to treat acute otitis media, in addition to
the possibility of predisposing patients to antibiotic
resistance, may add to the cost of treatment, especially
given that acute otitis media may resolve spontaneously
in older children.17,18 A more general consensus is to
recommend antibiotics to children younger than six
months, as they are more prone to develop complica-
tions if the middle ear is infected and the infection
becomes chronic.
Whether or not antibiotics are given will depend on
accurate diagnosis of the middle-ear infection and
assessment of the individual’s clinical and bacterio-
logical features. In this paper, we report the occurrence
of otitis media syndromes in children and assess the
efficacy of different management strategies.
Materials and methods
A total of 212 children aged 6 months to 10 years were
examined and treated for otitis media at the Lagos State
University Teaching Hospital, Ikeja, Nigeria, in a 13-
month study. The six-month-old babies included
those aged over five months. Permission to enrol
patients into the study was granted by the hospital’s
research and ethics committee. Admission into the
study was dependent on the provision of informed
written consent by parents or guardians. Exclusion cri-
teria were cholesteatoma and a history of antibiotic
therapy two months prior to presentation at clinic.
Clinical examinations included a review of: patients’
past medical history (e.g. history of upper respiratory
tract infection, previous diagnosis of otitis media and
medication details), routine biodata, the duration of
the disease and number of episodes, clinical features,
and otoscopic examination findings.
Features used to diagnose acute otitis media were:
acute onset with pain and irritation, middle-ear effu-
sion, opacification, and reduced or absent mobility of
the eardrum. Acute otitis media was diagnosed as per-
sistent if there was no resolution during antibiotic treat-
ment and cultures were positive for bacteria, or if
symptoms recurred within one month of treatment
completion (relapse) and cultures were positive for bac-
teria. A diagnosis of CSOM was dependent on persist-
ent symptoms for at least three months, with a scarred,
dull and/or retracted tympanic membrane on otoscopic
evaluation. Current and previous painless otorrhoea,
possibly accompanied by cold, sore throat and cough,
aided the diagnosis of CSOM.19
In all cases, aural toilet was initiated at the clinic with
warm saline solution. The child’s care giver was
advised to continue the treatment four times daily
using dry cotton wool wisps. Initial management of
acute otitis media was with paracetamol only
(15 mg/kg every 6 hours, for 48 hours). Antibiotics
were indicated in patients in whom symptoms persisted;
amoxicillin 80 mg/kg/day was given orally in two
divided doses for 7–10 days. When infection persisted,
treatment options were based on the culture results. In
most instances, amoxicillin-clavulanic acid was used.
The CSOMpatients were assigned into three treatment
groups: an amoxicillin group (n= 27), an amoxicillin-
clavulanic acid combination group (n= 27) (empirical
groups), and a treatment group based on culture and
antibiotic susceptibility test results (n= 28). Clinical
responses and bacteriological findings were recorded.
In the culture and antibiotic susceptibility test group,
the specimens for culture analysis were collected before
antibiotics were given. In the other cases, the speci-
mens were collected on completion of treatment and
when infection persisted or relapse occurred. Sterile
disposable pipettes (VWR®) were used to aspirate
middle-ear fluid that drained into the external auditory
canal. Specimens were collected in duplicate for
aerobic and anaerobic bacteria culture analyses.5
Pathogens were identified by conventional microbio-
logical methods.
Results
Of the 212 children in the study, 130 (61.3 per cent)
presented with symptoms of acute otitis media and 82
(38.7 per cent) were diagnosed with CSOM. The age
distribution of the children with otitis media is shown
in Figure 1. Twenty-five (19.2 per cent) of the acute
otitis media patients were aged 6 months, 46 (35.4
per cent) were 7–12 months, 28 (21.5 per cent) were
>1–2 years, 19 (14.6 per cent) were >2–5 years and
12 (9.2 per cent) were >5–10 years. The incidence
of acute otitis media in the first year of life was 54.6
per cent. Seven (8.5 per cent) of the CSOM patients
were aged 6 months, 30 (36.6 per cent) were 7–12
months, 15 (18.3 per cent) were >1–2 years, 12
(14.6 per cent) were >2–5 years and 18 (22 per cent)
were >5–10 years. The incidence of CSOM in the
first year of life was 45.1 per cent.
FIG. 1
Age distribution of children with otitis media. AOM= acute otitis
media; CSOM= chronic suppurative otitis media
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There were 48 (36.9 per cent) cases of non-resolving
acute otitis media following paracetamol, while 82
(63.1 per cent) cases of acute otitis media resolved
without antibiotic therapy. Non-resolving acute otitis
media was more common in infants aged 7–12
months (43.5 per cent) and in children aged >2–5
years (42.1 per cent) than in other age groups. Non-
resolving cases were treated empirically with amoxicil-
lin. If the infection persisted, patients were given
amoxicillin-clavulanic acid combination treatment
(amoxicillin 90 mg/kg/day and clavulanate 6.4 mg/
kg/day for 7–10 days depending on the age of the
patient) if the culture results indicated sensitivity.
Based on responses to paracetamol and antibiotic
therapy, 22.9 per cent of the acute otitis media cases
were classified as persistent and 2.1 per cent as
relapse cases (Table I).
All patients with chronic infections had otorrhoea.
Recovery occurred in 19 patients (70.4 per cent) in
the amoxicillin group, in 24 patients (88.9 per cent)
in the amoxicillin-clavulanic acid group and in 27
patients (96.4 per cent) in the culture and antibiotic sus-
ceptibility test group. Relapses were observed only in
the amoxicillin group (five cases) and amoxicillin-
clavulanic acid group (two cases). Infection persisted
in eight, three and one of the patients in the amoxicillin,
amoxicillin-clavulanic acid and culture and antibiotic
susceptibility test groups, respectively (Table II).
Aerobic and anaerobic bacteria isolated from infec-
tious cases of acute otitis media (for which antibiotics
were effective), and the persisting flora in CSOM cases
following antibiotic therapy, are given in Table III.
Pseudomonas aeruginosa was the most common of
the pathogens in those who experienced relapses or in
refractory cases.
Discussion
In this study, 54.6 per cent of the acute otitis media
cases occurred in the first year of life, thus highlighting
a critical group for therapeutic consideration. This
becomes more significant when one considers that
the trend was maintained in CSOM cases. These find-
ings justify in part why antibiotics should be given to
children aged one year or younger who are clinically
diagnosed with acute otitis media.13,14
The magnitude of the problem is evident from the
study findings of Morris et al.20 In their study of
Aboriginal children aged 6–30 months, 1 in every 2
children examined had otoscopic signs consistent
TABLE I
CHARACTERISATION AND INCIDENCE OF ACUTE OTITIS MEDIA IN CHILDREN
Characteristic Patient age Total
6 months 7–12 months >1–2 years >2–5 years >5–10 years
Total 25 (19.2) 46 (35.4) 28 (21.6) 19 (14.6) 12 (9.2) 130 (100)
Resolving AOM 18 (72) 26 (56.5) 18 (64.3) 11 (57.9) 9 (75) 82 (63.1)
Non-resolving AOM∗ 7 (28) 20 (43.5) 10 (35.7) 8 (42.1) 3 (25) 48 (36.9)
Persistent symptoms 3 (6.2) 5 (10.4) 2 (4.2) 1 (2.1) 0 (0) 11 (22.9)
Relapse occurred 0 (0) 1 (2.1) 0 (0) 0 (0) 0 (0) 1 (2.1)
Bacteriological cure 4 (8.3) 14 (29.2) 8 (16.7) 7 (14.6) 3 (6.2) 36 (75)
Data represent numbers (and percentages) of patients. ∗Defined as symptom persistence or relapse in patients with non-resolving infection
during or after antibiotic treatment respectively. AOM= acute otitis media
TABLE III
SUMMARY OF DATA ON BACTERIAL AETIOLOGY OF
OTITIS MEDIA
Bacterial AOM treated successfully∗
Aerobes
– Haemophilus influenzae (12)
– Moraxella catarrhalis (8)
– Methicillin-sensitive Staphylococcus aureus (66)
– Streptococcus pneumoniae (32)
– Streptococcus pyogenes (6)
Anaerobes
– Fusobacterium necrophorum (10)
– Fusobacterium nucleatum (4)
– Peptostreptococcus anaerobius (13)
– Porphyromonas asaccharolytica (12)
Persisting bacterial CSOM†
Amoxicillin group
– Escherichia coli (1)
– Klebsiella pneumoniae (3)
– Pseudomonas aeruginosa (5)
– Staphylococcus aureus (2)
– Prevotella melaninogenica (2)
Amoxicillin-clavulanic acid group
– Escherichia coli (1)
– Pseudomonas aeruginosa (4)
Culture & antibiotic sensitivity test group (0)
Values in parentheses represent numbers of patients from whom
pathogens were isolated. ∗With amoxicillin or amoxicillin-clavu-
lanic acid. †Relapses or refractory cases. AOM= acute otitis
media; CSOM= chronic suppurative otitis media
TABLE II
CLINICAL RESPONSE TO CHRONIC SUPPURATIVE
OTITIS MEDIA TREATMENTS
Treatment group Outcome Relapse in
recovered group
Persistence Recovery
Amoxicillin∗ 8 (29.6) 19 (70.4) 5 (26.3)
Amoxicillin-
clavulanic acid†
3 (11.1) 24 (88.9) 2 (8.3)
Culture & antibiotic
sensitivity test‡
1 (3.6) 27 (96.4) 0 (0.0)
Data represent numbers (and percentages) of patients. ∗n= 27;
†n= 27; ‡n= 28
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with suppurative ear disease, and 1 in 4 children had a
perforated tympanic membrane. Turner et al. are of the
opinion that empirical antibiotic treatment should be
given to infants aged less than two months of age, as
antibiotic resistance was already present at this age.21
This is not unrelated to the increase in the production
of β-lactamases associated with Moraxella catarrhalis
and Haemophilus influenzae, which are amongst the
leading pathogens in acute otitis media.22
In our study, the incidence of otitis media was
highest in children aged 7–12 months. These findings
are consistent with a report published in the late
1980s in which the incidence of otitis media peaked
in the second six months of life.23 In that study, 62
per cent of children had one or more episodes of
acute otitis media and 17 per cent had three or more
episodes in the first year of life. Moreover, 83 per
cent of patients aged three years had experienced one
or more episodes of acute otitis media and 46 per
cent had experienced three or more episodes. It is
important to consider that a delay in intervention may
result in the associated complications of language diffi-
culty and hearing loss.7,24
Despite the need to halt the progression of otitis
media, available evidence cautions against the unregu-
lated use of antibiotics, as this has contributed to wide-
spread antibiotic resistance amongst clinically
pathogenic bacteria.21,22 This was well illustrated by
Nyquist et al., who evaluated the prescription pattern
of antibiotics by physicians in the USA for upper
respiratory tract infections, cold and bronchitis.25
These authors reported that antibiotics were prescribed
to 44 per cent of patients with common cold, 46 per
cent with upper respiratory tract infections and 75 per
cent with bronchitis. It is most significant that children
aged zero to four years received 53 per cent of all anti-
biotic prescriptions, and otitis media accounted for only
30 per cent; this highlights a very disturbing scenario.
• Most otitis media cases are treated empirically
with antibiotics
• A high percentage of acute otitis media cases
resolve in children aged over one year
• It is recommended that antibiotics are given to
children aged less than one year because of
associated hearing and speech complications
in recurring cases
• In this study, the incidences of acute otitis
media and chronic suppurative otitis media
were highest in children aged less than one
year
• B-lactam antibiotics remain the effective drug
of choice
In the present study, otitis media management was
restricted to aural toilet, an analgesic and oral antibio-
tics where necessary. The analgesic used was
paracetamol, employed to relieve excruciating pain in
patients presenting with acute otitis media. The high
rate of resolving acute otitis media in this study sup-
ports the concept of ‘watchful waiting’.4,6,26 In other
settings, these patients may have received antibiotics
for their otitis media, which would not have been bene-
ficial. In the present study, amoxicillin was given as
first-line drug. This resulted in bacteriological cure
and resolution of symptoms in 75 per cent of cases.
Amoxicillin-clavulanic acid was the second-line thera-
peutic option, with a success rate of 77.1 per cent. This
indicates the need for prompt microbiological assess-
ment with antibiotics sensitivity evaluation. This
becomes even more imperative when a Gram-negative
bacillus such as P aeruginosa is isolated.
Conclusion
The high rate of recurrence in acute otitis media cases,
and the success rate of antibiotic therapy for treating
both acute otitis media and CSOM, suggest that anti-
biotics should be considered, especially when culture
and sensitivity patterns are established.
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